Effect of TU-100 in Patients With Irritable Bowel Syndrome (IBS)
Status:
Completed
Trial end date:
2015-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the effects of 5g of Daikenchuto (TU-100) three times
per day (Daikenchuto [TU-100] is a botanical agent that modulates gastrointestinal nerves),
and placebo on rectal sensation (sensation ratings of urgency to defecate and sensation
threshold for pain) in response to rectal balloon distension by barostat in patients with
IBS.